Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 15,079.0 | $576K | 0.04% | -546.0 | -3.5% | $38.21 | +57.8% |
| 82 | MCD | MCDONALD'S CORP | Consumer Cyclical | 1,861.0 | $569K | 0.04% | -1K | -44.3% | $305.63 | -18.1% |
| 83 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 6,917.0 | $566K | 0.04% | -483.0 | -6.5% | $81.88 | -5.9% |
| 84 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 12,592.0 | $564K | 0.04% | -923.0 | -6.8% | $44.82 | -12.8% |
| 85 | CGON | CG ONCOLOGY INC | Healthcare | 13,145.0 | $546K | 0.04% | -220.0 | -1.6% | $41.52 | +87.2% |
| 86 | VCYT | VERACYTE INC | Healthcare | 12,881.0 | $542K | 0.04% | -909.0 | -6.6% | $42.10 | +3.0% |
| 87 | VERA | VERA THERAPEUTICS INC | Healthcare | 10,417.0 | $528K | 0.04% | -770.0 | -6.9% | $50.64 | -28.4% |
| 88 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 20,617.0 | $518K | 0.04% | -2K | -6.9% | $25.12 | +63.3% |
| 89 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 14,285.0 | $494K | 0.04% | -1K | -7.0% | $34.57 | +14.9% |
| 90 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 16,535.0 | $458K | 0.04% | -9K | -35.7% | $27.72 | -6.5% |
| 91 | DYN | DYNE THERAPEUTICS INC | Healthcare | 23,273.0 | $455K | 0.04% | -2K | -6.7% | $19.56 | -12.4% |
| 92 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 35,716.0 | $434K | 0.03% | -25K | -41.0% | $12.14 | -13.5% |
| 93 | — | AMER SPORTS INC | — | 11,537.0 | $431K | 0.03% | -25K | -68.2% | $37.35 | — |
| 94 | ADPT | ADAPTIVE BIOTECHNOLOGIES | Healthcare | 26,477.0 | $430K | 0.03% | -4K | -12.6% | $16.24 | +72.8% |
| 95 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 17,251.0 | $428K | 0.03% | -1K | -6.6% | $24.82 | +79.4% |
| 96 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 23,898.0 | $395K | 0.03% | -2K | -6.8% | $16.51 | +30.8% |
| 97 | CNTA | CENTESSA PHARMACEUTICALS-ADR | Healthcare | 15,721.0 | $393K | 0.03% | -1K | -6.5% | $25.01 | +61.9% |
| 98 | NTRA | NATERA INC | Healthcare | 1,600.0 | $367K | 0.03% | -400.0 | -20.0% | $229.09 | +70.6% |
| 99 | ANAB | ANAPTYSBIO INC | Healthcare | 7,512.0 | $364K | 0.03% | -2K | -24.2% | $32.32 | +66.8% |
| 100 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 15,721.0 | $362K | 0.03% | -1K | -6.9% | $23.00 | -32.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
40.3%
Healthcare
21.6%
Communication Services
10.8%
Financial Services
10.7%
Consumer Cyclical
10.3%
Consumer Defensive
2.8%
Industrials
2.0%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%